Yuling Bao

1.2k total citations
26 papers, 1.1k citations indexed

About

Yuling Bao is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Yuling Bao has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 10 papers in Biomedical Engineering and 9 papers in Molecular Biology. Recurrent topics in Yuling Bao's work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (5 papers). Yuling Bao is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (5 papers). Yuling Bao collaborates with scholars based in China. Yuling Bao's co-authors include Songwei Tan, Yuanyuan Guo, Xiangting Zhuang, Zhiping Zhang, Tingting Wu, Qingle Song, Xiaomeng Hu, Miao Kong, Dong Wang and Qi Yan and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and Journal of Controlled Release.

In The Last Decade

Yuling Bao

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuling Bao China 15 588 549 498 302 173 26 1.1k
Xiangting Zhuang China 7 481 0.8× 418 0.8× 368 0.7× 242 0.8× 128 0.7× 9 813
Cao Dai Phung South Korea 20 509 0.9× 296 0.5× 407 0.8× 350 1.2× 191 1.1× 33 1.0k
Yu Qin China 17 525 0.9× 392 0.7× 398 0.8× 234 0.8× 131 0.8× 31 1.1k
Suxin Li China 15 435 0.7× 284 0.5× 619 1.2× 534 1.8× 237 1.4× 42 1.4k
Qingle Song China 15 910 1.5× 486 0.9× 579 1.2× 532 1.8× 243 1.4× 26 1.4k
Kuo‐Ching Mei United States 18 490 0.8× 331 0.6× 438 0.9× 281 0.9× 171 1.0× 32 1.1k
Tianqun Lang China 17 568 1.0× 363 0.7× 393 0.8× 217 0.7× 179 1.0× 30 938
Tian Zhang China 19 739 1.3× 432 0.8× 526 1.1× 278 0.9× 152 0.9× 25 1.2k
Aihua Wu China 19 345 0.6× 307 0.6× 570 1.1× 273 0.9× 204 1.2× 37 1.2k
Mengnan Zhao China 14 433 0.7× 427 0.8× 616 1.2× 169 0.6× 75 0.4× 29 1.2k

Countries citing papers authored by Yuling Bao

Since Specialization
Citations

This map shows the geographic impact of Yuling Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Bao more than expected).

Fields of papers citing papers by Yuling Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuling Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Bao. The network helps show where Yuling Bao may publish in the future.

Co-authorship network of co-authors of Yuling Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuling Bao. A scholar is included among the top collaborators of Yuling Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuling Bao. Yuling Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bao, Yuling, Shuyuan Cao, Zhan Zhang, et al.. (2024). The investigation of the role of oral-originated Prevotella-induced inflammation in childhood asthma. Frontiers in Microbiology. 15. 1400079–1400079. 5 indexed citations
3.
Bao, Yuling, et al.. (2023). A Nomogram Model for Stratifying the Risk of Recurrence in Patients with Meningioma After Surgery. World Neurosurgery. 176. e644–e650. 2 indexed citations
4.
Wu, Hao, et al.. (2022). PAH-induced metabolic changes related to inflammation in childhood asthma. Environmental Science and Pollution Research. 30(5). 13739–13754. 6 indexed citations
5.
Bao, Yuling, Hui Huang, Zhan Zhang, et al.. (2021). The preliminary investigation of potential response biomarkers to PAHs exposure on childhood asthma. Journal of Exposure Science & Environmental Epidemiology. 32(1). 82–93. 14 indexed citations
6.
Bao, Yuling, Zhan Zhang, Li Wang, et al.. (2021). Correction to: The Preliminary Study on the Association Between PAHs and Air Pollutants and Microbiota Diversity. Archives of Environmental Contamination and Toxicology. 80(3). 659–659. 2 indexed citations
7.
Bao, Yuling, Zhan Zhang, Li Wang, et al.. (2020). The Preliminary Study on the Association Between PAHs and Air Pollutants and Microbiota Diversity. Archives of Environmental Contamination and Toxicology. 79(3). 321–332. 21 indexed citations
8.
Yang, Guan, et al.. (2020). Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment. Current Medical Science. 40(2). 218–231. 38 indexed citations
9.
Bao, Yuling, Qian Hu, Xiuping Wang, et al.. (2020). Chemo-immunotherapy with doxorubicin prodrug and erythrocyte membrane-enveloped polymer nano-vaccine enhances antitumor activity. Biomedicine & Pharmacotherapy. 129. 110377–110377. 10 indexed citations
10.
Chen, Meng, et al.. (2019). Microbial contributions to bronchial asthma occurrence in children: A metagenomic study. Journal of Cellular Biochemistry. 120(8). 13853–13860. 3 indexed citations
11.
Yin, Mingxing, Songwei Tan, Yuling Bao, & Zhiping Zhang. (2017). Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy. Journal of Controlled Release. 258. 108–120. 50 indexed citations
12.
Wu, Tingting, Yan Qi, Dan Zhang, et al.. (2017). Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor. Advanced Functional Materials. 27(42). 47 indexed citations
13.
Yin, Mingxing, Yuling Bao, Xueqin Gao, et al.. (2017). Redox/pH dual-sensitive hybrid micelles for targeting delivery and overcoming multidrug resistance of cancer. Journal of Materials Chemistry B. 5(16). 2964–2978. 38 indexed citations
14.
Hu, Xiaomeng, Tingting Wu, Yuling Bao, & Zhiping Zhang. (2017). Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense. Journal of Controlled Release. 256. 26–45. 44 indexed citations
15.
Bao, Yuling, Miao Kong, Xueqin Gao, et al.. (2017). pH-, redox dual-sensitive poly(β-amino ester)-g-TPGS copolymer nanoparticles for drug delivery and inhibition of multidrug resistance in cancer. Reactive and Functional Polymers. 120. 131–138. 14 indexed citations
16.
Chu, Qian, Xun Yuan, Wenxiang Ji, et al.. (2016). A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. International Journal of Nanomedicine. 11. 2119–2119. 26 indexed citations
17.
Bao, Yuling, Mingxing Yin, Xiaomeng Hu, et al.. (2016). A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Journal of Controlled Release. 235. 182–194. 129 indexed citations
18.
Zhuang, Xiangting, Tingting Wu, Yongdan Zhao, et al.. (2016). Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2Kb and H-2Db-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma. Journal of Controlled Release. 228. 26–37. 79 indexed citations
19.
Chu, Qian, et al.. (2015). D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. International Journal of Nanomedicine. 10. 5219–5219. 26 indexed citations
20.
Bao, Yuling, Yuanyuan Guo, Xiangting Zhuang, et al.. (2014). d-α-Tocopherol Polyethylene Glycol Succinate-Based Redox-Sensitive Paclitaxel Prodrug for Overcoming Multidrug Resistance in Cancer Cells. Molecular Pharmaceutics. 11(9). 3196–3209. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangting Zhuang Breakdown of academic impact, for papers by Cao Dai Phung Breakdown of academic impact, for papers by Yu Qin Breakdown of academic impact, for papers by Suxin Li Breakdown of academic impact, for papers by Qingle Song Breakdown of academic impact, for papers by Kuo‐Ching Mei Breakdown of academic impact, for papers by Tianqun Lang Breakdown of academic impact, for papers by Tian Zhang Breakdown of academic impact, for papers by Aihua Wu Breakdown of academic impact, for papers by Mengnan Zhao
Rankless by CCL
2026